However, weight loss and better metabolic health, which semaglutide can promote, might contribute to improved energy levels in some individuals, though this is not guaranteed
These include: Body mass index (BMI) over 30% BMI over 27% and at least one serious medical condition due to weight, such as high blood pressure We have guidelines to help us determine who is a good fit for these medications, but doctors should always use their professional judgment, Dr
Semaglutide In a prospective study, Semaglutide decreased binge frequency and craving intensity, and improved Binge Eating Scale scores
[8] [9] However, it is important to note that UDCA use for gallstone prevention in patients taking GLP-1 agonists would be off-label, and there is limited evidence for this specific population
Lean ME, Leslie WS, Barnes AC et al (2018) Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial